Patricia Bradford

Does your company have an antibacterial in clinical development? Would you like to be included in the New Agents session at the IMARI meeting in January? Apply here: app.smartsheet.com/b/form/01985...
Deadline is Dec. 1
#IDSky

Crowdsourcing some information: For the IMARI meeting we are doing a retrospective on projects highlighted in the New Agents sessions at ICCAC/Microbe in the past and are missing info for yrs 2015 and beyond. Did you or a colleague speak in one of those sessions? Please reply in the comments
#IDSky

IMARI 2026 Visit the post for more.

So excited for this meeting- a long overdue follow on to ICAAC. Submit your abstracts and hope to see you there. #IDSky

imari.org

George L. Drusano Obituary (2025) - Whitman, MA - Blanchard Funeral Chapel & Cremation Service View George L. Drusano's obituary, send flowers and sign the guestbook.

Some sad news. George will be missed
#IDSky

www.legacy.com/us/obituarie...

SAND: a comprehensive annotation of class D β-lactamases using structural alignment-based numbering | Antimicrobial Agents and Chemotherapy Class D β-lactamases (DBLs) form a large family with nearly 1,300 identified members in the β-Lactamase Database (Fig. S1, www.bldb.euhttp://www.bldb.eu/) (1). They are produced mainly by Gram-negative bacteria, with some by Gram-positive bacteria (2). DBLs are an important mechanism of resistance to β-lactam antibiotics, including carbapenems, one of last resort treatments to infections in hospitalized patients (3). The production of class D β-lactamases is a major public health concern, as they can often transfer between different bacterial species, allowing resistance to spread quickly and widely. Some members were found to be membrane-bound and are secreted via outer membrane vesicles (OMVs) to contribute further in antimicrobial resistance dissemination (4). Their mechanism of action involves a catalytic serine, as in classes A and C β-lactamases, since all share the conserved SXXK tetrad and KXG triad (3).

Check out this new scheme for class D b-lactamases. SAND: a comprehensive annotation of class D β-lactamases using structural alignment-based numbering | Antimicrobial Agents and Chemotherapy journals.asm.org/doi/10.1128/...

Such a good book

The deadline for the expression of interest is approaching. Submit your… | Patricia Bradford The deadline for the expression of interest is approaching. Submit your ideas!

www.linkedin.com/posts/patric...

The 2025 Vivli AMR Surveillance Data Challenge, funded by Johnson & Johnson, Paratek, Pfizer, and an NIH award* is now OPEN. Head to lnkd.in/djaXB-PX to read about the challenge and how to enter. Expressions of interest must be received by 26-May-2025. #AMR

I’ll be interested to see how many Qs you get here vs Twitter. This app isn’t very use friend for finding content

100% incorrect

Please join Vivli at NIH’s Data Sharing and Reuse Seminar Series: The Vivli AMR Data Challenge as a Use Case | Friday, March 14 at 12:00 pm ET | Register at scgcorp.zoom.us/webinar/regi...

Science: sometimes it just takes a little protocol tweak

Petri (1887) Centralblatt fur Bacteriologie und Parasitenkunde

“A minor modification of the plating technique of Koch...under these conditions, contamination from airborne germs rarely occurs”

His modification?

A͓̽ ͓̽L͓̽I͓̽D͓̽ ͓̽F͓̽O͓̽R͓̽ ͓̽T͓̽H͓̽E͓̽ ͓̽A͓̽G͓̽A͓̽R͓̽ ͓̽D͓̽I͓̽S͓̽H͓̽

This conference is long awaited and much needed following the demise of ICAAC. I can’t wait to see how this develops @asm.org

asm.org/Press-Releas...

Once again, it was inspiring to see the creative uses of the data from the challenge participants
amr.vivli.org/winners-anno...